Stay updated on Pembrolizumab in Thymic Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Thymic Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Recruitment status now indicates no longer looking for participants, clarifying enrollment availability. The page adds new user guidance sections and adjusts the Intervention/Treatment heading formatting, along with a version note.
    Difference
    0.5%
    Check dated 2026-06-12T16:32:16.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page version was updated from v3.5.4 to v3.5.5, indicating a new release of the page template or rendering without altering the study content shown to users.
    Difference
    0.1%
    Check dated 2026-06-05T12:08:14.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, indicating a small backend/metadata update. There are no substantive changes to the study information or user-visible content.
    Difference
    0.1%
    Check dated 2026-05-14T23:15:27.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.5.2 to v3.5.3. This indicates a small back-end update to the page that does not appear to affect the study content or data.
    Difference
    0.1%
    Check dated 2026-04-30T15:36:45.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T09:51:12.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T20:24:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Thymic Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.